4-aminopyridine has been researched along with donepezil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sen, S; Sinha, N | 1 |
Poorheidari, G; Pratt, JA; Stanhope, KJ | 1 |
Averill, A; Farag, A | 1 |
3 other study(ies) available for 4-aminopyridine and donepezil
Article | Year |
---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Effects of the potassium channel blockers, apamin and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020.
Topics: 4-Aminopyridine; Animals; Apamin; Choice Behavior; Cholinesterase Inhibitors; Conditioning, Operant; Donepezil; Indans; Male; Muscarinic Antagonists; Piperidines; Potassium Channel Blockers; Potassium Channels; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine | 1998 |
Dalfampridine: is the seizure risk greater than previously thought?
Topics: 4-Aminopyridine; Donepezil; Follow-Up Studies; Humans; Indans; Middle Aged; Multiple Sclerosis; Piperidines; Potassium Channel Blockers; Risk Assessment; Seizures; Severity of Illness Index | 2013 |